Everything You Need to Know About Cervical Cancer – Symptoms, Risk Factors and More

5 minute read

By Gerald Morris

Cervical cancer is a slow-developing but serious disease that often progresses silently, making awareness of symptoms and risk factors incredibly important. While early stages may show no signs, understanding how cervical cancer develops and recognizing subtle changes in your health can lead to earlier detection and more effective treatment. With factors like HPV, smoking, and immune health playing major roles, staying informed empowers women to take proactive steps toward prevention, timely screening, and improved long-term outcomes.

Signs and Symptoms

Since this disease progresses slowly, it is common for women with early-stage cervical cancers to have no signs or symptoms. As cervical cancer progresses, it may lead to signs and symptoms, such as:

Additionally, if cervical cancer has spread to nearby or distant organs, symptoms may include:

Risk Factors

No one knows exactly what causes cervical cancer. However, one of the main risk factors for this disease is human papillomavirus (HPV). According to the Centers for Disease Control and Prevention (CDC), HPV is the most common sexually transmitted infection (STI) in the United States. Additionally, a diagnosis of another STI, such as chlamydia, gonorrhea, syphilis, or HIV, increases your risk for HPV. There are more than 100 types of HPV, of which approximately 13 types have the potential to cause cervical cancer.

Although HPV may cause genital warts, it should be noted that they are very common. Most people with this diagnosis do not go on to develop cervical cancer, especially with the availability of HPV vaccines today.

Other risk factors for cervical cancer include:

Furthermore, ethnicity is a risk factor. As such, Hispanic women at greatest risk for cervical cancer, followed by African American, Asian/Pacific Islander, and Caucasian women. In fact, American Indian and Alaskan native women are at the lowest risk for cervical cancer in the United States.

Lastly, if your mother was administered a miscarriage prevention drug called diethylstilbestrol in the 1950s, you are at increased risk for cervical cancer.

Types

Cervical cancers are classified by their appearance under a microscope. As such, there are two main types of cervical cancer:

  1. Squamous cell carcinoma
  2. Adenocarcinoma.

The great majority — 90 percent in fact — of cervical cancers are squamous cell carcinomas. They typically develop in exocervical cells and have thin, flat sheets of cells under the microscope.

The rest of the cervical cancers are adenocarcinomas. They typically develop in endocervical cells, which are mucus-producing glands.

Occasionally, both types of cells are involved in cervical cancer. This type is adenosquamous carcinoma or mixed carcinoma. Very rarely does cervical cancer occur in other types of cells within the cervix.

Stages

The stage of your cervical cancer is one of the most important determinants of your treatment plan. Knowing the stage provides insight into how successful treatment might be.

Cervical cancer can be categorized by the following stages:

It should be kept in mind that Stages I to III may or may not be characterized by the spread of cervical cancer cells to local lymph nodes. Also, Stage IV is the most advanced stage of the disease.

Prognosis

The ACS references information from the Surveillance, Epidemiology, and End Results (SEER) database to provide five-year relative survival rates for cervical cancer. Think of a relative five-year relative survival rate as comparing women who have cervical cancer with women who don’t have cervical cancer and their propensity to live at least five years after their cancer diagnosis.

The SEER database groups cervical cancers into three categories. They are:

  1. Localized Disease: Confined to the cervix/uterus.
  2. Regional Disease: Cancer has grown outside of cervix/uterus to neighboring structures.
  3. Distant Disease: Cancer has spread to other parts of the body.

The prognosis for cervical cancer (with treatment) is good. Additionally, five-year relative survival rates were 91 percent for localized disease (Stage I), 62 percent for regional disease (Stage II and III), and 19 percent for distant disease (Stage IV). These results lend validity to the early diagnosis of cervical cancer through screening programs, which should increase your chances of survival.

It should be kept in mind that these five-year relative survival rates are averages and do not apply to everyone. There have been reports of successful treatment of Stage IV cervical cancer.

Living with Cervical Cancer

If you have or have had cervical cancer, you may want to know if there are things you can do to potentially lower your risk of cancer progression or recurrence. Some general recommendations for women living with cervical cancer include:

No one really knows if the adoption of these behaviors will prevent or treat cervical cancer. However, many believe the positive effects on your health as a result of these behaviors can extend to lowering your risk of cervical cancer progression or recurrence.

Moving Forward with Knowledge and Confidence

Living with cervical cancer or navigating a new diagnosis can feel overwhelming, but understanding your condition is one of the most powerful tools you have. Early detection offers the strongest path toward successful treatment, and knowing the symptoms, risk factors, and staging helps you make informed decisions with your healthcare team. Taking care of your overall health through exercise, balanced nutrition, rest, and smoking cessation may also support your body throughout treatment and recovery.

While no lifestyle changes guarantee prevention or remission, nurturing your physical well-being and staying engaged in follow-up care can improve your quality of life. Most importantly, remember that every individual’s journey is unique. With the right support, consistent medical guidance, and ongoing awareness, you can face cervical cancer with clarity, resilience, and hope.

Gerald Morris

Contributor